logo
MRF shares fall nearly 1% amid crude oil price spike following Israel-Iran conflict

MRF shares fall nearly 1% amid crude oil price spike following Israel-Iran conflict

Business Upturn3 days ago

By Aditya Bhagchandani Published on June 13, 2025, 09:40 IST
Shares of MRF Ltd slipped 0.51% to ₹1,35,690 in Friday's session as investors turned cautious amid a surge in global crude oil prices triggered by rising geopolitical tensions in the Middle East. The Israel-Iran conflict has pushed Brent crude prices above $77 per barrel, a rise of over 10%, raising concerns about higher input costs for tyre manufacturers like MRF.
MRF, one of India's leading tyre makers, relies heavily on petroleum-based raw materials such as synthetic rubber and processing oils. A sharp increase in crude oil prices significantly impacts the company's production costs and operating margins.
The stock movement is in line with broader weakness across sectors vulnerable to oil inflation, including aviation, paints, logistics, and chemicals. Analysts expect continued pressure on tyre stocks like CEAT and Apollo Tyres as well if oil prices remain elevated.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions.
Ahmedabad Plane Crash
Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

MRF shares fall nearly 1% amid crude oil price spike following Israel-Iran conflict
MRF shares fall nearly 1% amid crude oil price spike following Israel-Iran conflict

Business Upturn

time3 days ago

  • Business Upturn

MRF shares fall nearly 1% amid crude oil price spike following Israel-Iran conflict

By Aditya Bhagchandani Published on June 13, 2025, 09:40 IST Shares of MRF Ltd slipped 0.51% to ₹1,35,690 in Friday's session as investors turned cautious amid a surge in global crude oil prices triggered by rising geopolitical tensions in the Middle East. The Israel-Iran conflict has pushed Brent crude prices above $77 per barrel, a rise of over 10%, raising concerns about higher input costs for tyre manufacturers like MRF. MRF, one of India's leading tyre makers, relies heavily on petroleum-based raw materials such as synthetic rubber and processing oils. A sharp increase in crude oil prices significantly impacts the company's production costs and operating margins. The stock movement is in line with broader weakness across sectors vulnerable to oil inflation, including aviation, paints, logistics, and chemicals. Analysts expect continued pressure on tyre stocks like CEAT and Apollo Tyres as well if oil prices remain elevated. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.

Oil spike, risk off on Middle East flare up may drag Indian rupee past 86/USD
Oil spike, risk off on Middle East flare up may drag Indian rupee past 86/USD

Business Recorder

time3 days ago

  • Business Recorder

Oil spike, risk off on Middle East flare up may drag Indian rupee past 86/USD

MUMBAI: The Indian rupee is expected to slip past 86 to the U.S. dollar at the open on Friday, hit by surging oil prices and sliding risk assets after Israel attacked targets in Iran. The 1-month non-deliverable forward indicated a open in the 86.02 to 86.10 range, versus 85.60 in the previous session. Brent crude soared 11%, U.S. equity futures plunged 1.8% and safe-haven demand boosted the struggling dollar. 'The real concern for the rupee isn't just today's oil spike - it's the risk of a sustained rally if Middle East tensions deepen,' a currency trader at a Mumbai-based bank said. According to the trader, the 86.00 to 86.10 zone is a major support for the rupee, though he warned that defending it 'will be challenging'. Indian rupee ends a tad lower, hurt by corporate dollar bids, outflows Israel said it targeted Iran's nuclear facilities, ballistic missile factories and military commanders on Friday, warning that it marked the beginning of a sustained campaign aimed at preventing Tehran from building an atomic weapon. Another report suggested that explosions were heard northeast of Iran's capital Tehran. The strikes by Israel came amid mounting tensions over U.S. efforts to halt Iran's production of atomic bomb materials. 'Markets will carefully assess the risk of escalation,' DBS Research said in a note. Safe-haven demand lifted the Japanese yen and the Swiss franc and helped the dollar index recover to the 98 handle. The 10-year U.S. yield dropped despite the jump in oil. Brent crude is potentially headed for its biggest one-day rise in over three years. Oil is a major component of India's import bill. A $10 barrel increase in crude can widen the current account deficit by up to 0.4% of GDP, economists estimate, and can add up to 35 basis points to headline consumer inflation.

Short covering anticipated next week; bullish on 4 pharma & defence stocks: CA Rudramurthy BV
Short covering anticipated next week; bullish on 4 pharma & defence stocks: CA Rudramurthy BV

Time of India

time3 days ago

  • Time of India

Short covering anticipated next week; bullish on 4 pharma & defence stocks: CA Rudramurthy BV

CA Rudramurthy BV , MD, Vachana Investments, sees a buying opportunity in Nifty around 24,800, targeting 25,600. Bank Nifty has broken above 54,500, with 55,900-56,000 as strong support. Dips to these levels are buying opportunities , targeting 58,000 and 60,000. Despite Thursday's weakness due to geopolitical concerns, 25,000 is expected to hold. Short covering is anticipated next week, given high FII net short positions. Rudramurthu is bullish on pharma and defence sectors and highlights Divi's Lab , Laurus Lab , HAL , and BEL as top picks. Attractive opportunities also exist in chemicals with Navin Fluro and Tata Chemical, insurance with HDFC Life and SBI Life, and mid-sized banks like RBL Bank and Federal Bank. How do you see the trade happening on Nifty as well as Bank Nifty? CA Rudramurthy BV: First of all, for today's expiry, the Iran-Israel issue has been a hangover and because of that reason we are seeing the dip in market but I am very clear that the 25,000 level on Nifty is a very strong support. In fact, positional traders should use this opportunity and buy the dip. For me till 24,800 holds, this market is a buy on every dip. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like The Killer New Toyota 4Runner Is Utter Perfection (Take A Look) MorninJoy Undo So, for me, at the current market price and on dips to 24,800 is a buying opportunity in Nifty. I am looking at targets of 25,600 to come. When it comes to Bank Nifty, we have already seen a breakout above 54,500. Now that level of around 55,900-56,000 is acting as a very strong support. Any dips to 56,000-55,900 is a great buying opportunity and I am looking at targets of 58,000 and then 60,000 to come on Bank Nifty. Yes, for Thursday's expiry, the market looks weak because of that Iran-Israel issue. However, I feel 25,000 will be strongly held even for today and for a positional trader, it is a godsend opportunity to buy this dip and I am looking at targets of 25,600 to come very soon in Nifty. More short covering will come. FII net short position is currently at around 78-80% and from here on, I expect more short covering to come in next week. Similarly, the volatility index now is below 14, India VIX is comfortable, and more short covering will come from the current level. We are at a strong support of 25,000, all good fundamentally, and even the RBI policy was spectacular with a reported 50 basis point repo rate cut as well as a 100 bps CRR cut. What more do you want? This market is a buy on dip and definitely no shorting whatsoever. Live Events You Might Also Like: Fresh triggers could take Nifty to 25,300–25,500: Analysts What about the broader end of the market because we have seen them tip into the red yesterday but today for the first time in a very long time, the broader markets are underperforming the benchmark. What is your take on the broader end of the market – the midcap and smallcap both trading with cuts of about eight-tenth of a percent as we speak? CA Rudramurthy BV: After a correction in the longer term bull market, the October to March correction was done and then, we saw from April this year largecaps participating till May mid or even till close of May. But now from May 15th onwards, we have seen the broader market participating and in general yes, the broader market overall will do good from current market price. We have to be very sector specific and stock specific in this market. Yes, we first saw the private banks rallying. Later on, the move has started in mid-sized banks and PSUs have also started rallying. We are seeing even good moves in defence, railway and shipping stocks. So, one has to be very sector specific and stock specific and at current market price I am very bullish on two sectors – pharma and defence. To name some of the stocks in pharma, both Divi's Lab and Laurus Lab are trading close to all-time highs of their price and for me they are very bullish. So, yes, one can look at buying Divi's and Laurus Lab. Two more attractive pharma stocks are Glenmark and Biocon. So, for me, from now on, pharma will do very good and you have a long way to go from current market price. For me defence as a theme is also very good. HAL and BEL are my top picks. Even at current market prices, buy into HAL and BEL. Use opportunities like dips to buy into pharma as well as the defence stocks . But I am still bullish on chemicals. Look at stocks like Navin Fluro, Tata Chemical, they are all looking good, SRF. From insurance, HDFC Life and SBI Life look very good. LIC is also another stock which you can look for. Mid-sized banks will do very good. RBL Bank, Bandhan Bank looks very attractive. Even Federal Bank for that matter. You Might Also Like: $1 Trillion GDP Boost in Sight: Abhishek Banerjee on promising sectors, gold and market sentiment For me, PSU banks also look very attractive whether it is Canara Bank or Punjab National Bank or even State Bank of India and it has also started a move from Wednesday. For me Coforge, Tech Mahindra, and Persistent Systems look very strong. You have to be very specific in your stocks and pick the right sectors. So, for me pharma, defence, chemicals, and then mid-sized banks are all stocks which will do very well from current market price. So, these sectors and stocks look very attractive to me.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store